文献速递关节外科

延长口服抗生素预防高危患者假体周围感染:3855例1年随访

The AAHKS Clinical Research Award: Extended Oral Antibiotics Prevent Periprosthetic Joint Infection in High-Risk Cases: 3855 Patients With 1-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2021-01-23

该回顾性研究纳入2011至2019年3855例初次全髋和全膝关节置换术患者,2015年起对高危患者出院后实施7天口服抗生素预防方案。结果显示高危患者接受预防后1年假体周围感染率显著低于未接受者(0.89% vs 2.64%,P < .001),且与低危患者无差异(P = .348)。结论认为延长口服抗生素可显著降低高危患者1年感染率。

要点

  • 高危患者接受7天口服抗生素预防后1年PJI率为0.89%,显著低于未预防者的2.64%。
  • 接受抗生素的高危患者PJI率与低危患者(1.29%)无统计学差异(P = .348)。
  • 全髋和全膝置换术后1年总体感染率分别为2.26%和0.85%。

核心结论

  • 出院后延长7天口服抗生素预防可显著降低高危患者初次全髋和全膝关节置换术后1年假体周围感染率。
  • 接受抗生素预防的高危患者PJI率甚至低于低危患者,提示该措施可能有效抵消不良宿主因素。

研究设计与样本

  • 回顾性 review 了2011至2019年间在郊区学术医院连续实施的3855例初次全髋和全膝关节置换术,该院采用现代围手术期和感染预防方案。
  • 自2015年1月起对PJI高危患者出院后实施7天口服抗生素预防方案,比较接受与未接受预防的高危患者1年内PJI诊断百分比。
  • 采用单因素和逻辑回归分析,P ≤ .05为统计学显著,证据等级为治疗性III级。

主要发现

  • 全髋和全膝关节置换术后总体1年感染率分别为2.26%和0.85%。
  • 高危患者中接受延长抗生素预防者PJI率为0.89%,未接受者为2.64%,差异显著(P < .001)。
  • 接受抗生素的高危患者与低危患者感染率分别为0.89%和1.29%,无统计学差异(P = .348)。

关键数值与推荐

  • 高危患者接受出院后7天口服抗生素预防,其1年PJI率为0.89%,未接受者为2.64%(P < .001)。
  • 接受抗生素的高危患者与低危患者1年PJI率分别为0.89%和1.29%(P = .348)。

临床怎么用

  • 对于存在PJI高危因素的患者,可考虑在出院后实施7天延长口服抗生素预防以降低1年感染风险。
  • 该方案可能减少基于结果的支付模型中挑选更健康患者的动机,但需多中心随机对照试验进一步验证。

局限性

  • 本研究为单中心回顾性 review,证据等级为治疗性III级,需多中心随机对照试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical and host factors predispose patients to periprosthetic joint infection (PJI) after primary total hip arthroplasty (THA) and total knee arthroplasty (TKA). While surgical factors are modifiable, host factors can be challenging, and there are limited data demonstrating that preoperative patient optimization decreases risk of PJI. The goal of this study was to evaluate whether extended oral antibiotic prophylaxis reduces the one-year infection rate in high-risk patients. METHODS: A total of 3855 consecutive primary THAs and TKAs performed between 2011 and 2019 at a suburban academic hospital with modern perioperative and infection-prevention protocols were retrospectively reviewed. Beginning in January 2015, a 7-day oral antibiotic prophylaxis protocol was implemented after discharge for patients at high risk for PJI. The percentage of high-risk patients diagnosed with PJI within 1 year was compared between groups that did and did not receive extended antibiotic prophylaxis. Univariate and logistic regression analyses were performed, with P ≤ .05 denoting statistical significance. RESULTS: Overall 1-year infection rates were 2.26% and 0.85% after THA and TKA, respectively. High-risk patients with extended antibiotic prophylaxis had a significantly lower rate of PJI than high-risk patients without extended antibiotic prophylaxis (0.89% vs 2.64%, respectively; P < .001). There was no difference in the infection rate between high-risk patients who received antibiotics and low-risk patients (0.89% vs 1.29%, respectively; P = .348) with numbers available. CONCLUSION: Extended postoperative oral antibiotic prophylaxis for 7 days led to a statistically significant and clinically meaningful reduction in 1-year infection rates of patients at high risk for infection. In fact, the PJI rate in high-risk patients who received antibiotics was less than the rate seen in low-risk patients. Thus, extended oral antibiotic prophylaxis may be a simple measure to effectively counteract poor host factors. Moreover, the findings of this study may mitigate the incentive to select healthier patients in outcome-based reimbursement models. Further study with a multicenter randomized control trial is needed to further validate this protocol. LEVEL OF EVIDENCE: Therapeutic level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kheir MM, Dilley JE, Ziemba-Davis M, et al. The AAHKS Clinical Research Award: Extended Oral Antibiotics Prevent Periprosthetic Joint Infection in High-Risk Cases: 3855 Patients With 1-Year Follow-Up. J Arthroplasty. 2021. PMID: 33589279. doi:10.1016/j.arth.2021.01.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。